Junichi Sakamoto

3.6k total citations
149 papers, 2.5k citations indexed

About

Junichi Sakamoto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Junichi Sakamoto has authored 149 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 39 papers in Pulmonary and Respiratory Medicine and 33 papers in Surgery. Recurrent topics in Junichi Sakamoto's work include Colorectal Cancer Treatments and Studies (52 papers), Colorectal Cancer Surgical Treatments (32 papers) and Cancer Treatment and Pharmacology (30 papers). Junichi Sakamoto is often cited by papers focused on Colorectal Cancer Treatments and Studies (52 papers), Colorectal Cancer Surgical Treatments (32 papers) and Cancer Treatment and Pharmacology (30 papers). Junichi Sakamoto collaborates with scholars based in Japan, United States and Vietnam. Junichi Sakamoto's co-authors include Yasuo Ohashi, Kenneth O. Lloyd, Hiroaki Nakazato, Koji Oba, Satoshi Morita, Tsuguya Fukui, Mahbubur Rahman, Lloyd J. Old, Takanori Matsui and Shigetoyo Saji and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemistry.

In The Last Decade

Junichi Sakamoto

144 papers receiving 2.4k citations

Peers

Junichi Sakamoto
Manisha Bhutani United States
Ramez N. Eskander United States
Robert L. Capizzi United States
E. Masuyer France
Gareth J. Veal United Kingdom
Robert E. Falcone United States
Manisha Bhutani United States
Junichi Sakamoto
Citations per year, relative to Junichi Sakamoto Junichi Sakamoto (= 1×) peers Manisha Bhutani

Countries citing papers authored by Junichi Sakamoto

Since Specialization
Citations

This map shows the geographic impact of Junichi Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Sakamoto more than expected).

Fields of papers citing papers by Junichi Sakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Sakamoto. The network helps show where Junichi Sakamoto may publish in the future.

Co-authorship network of co-authors of Junichi Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Sakamoto. A scholar is included among the top collaborators of Junichi Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Sakamoto. Junichi Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yasui, Takeshi, Takeshi Yamamoto, Nozomu Sakai, et al.. (2017). Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design. Bioorganic & Medicinal Chemistry. 25(17). 4876–4886. 21 indexed citations
5.
Niida, Ayumu, Tomoko Asakawa, Hisashi Fujita, et al.. (2017). Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives. Bioorganic & Medicinal Chemistry. 26(3). 566–572. 8 indexed citations
6.
Yamaguchi, Shigeki, Katsuyuki Kunieda, Masaaki Kobayashi, et al.. (2016). Phase III trial of 24 weeks vs. 48 weeks capecitabine adjuvant chemotherapy for patients with stage III colon cancer: Final results of JFMC37-0801. Annals of Oncology. 27. vi155–vi155. 2 indexed citations
7.
Sakamoto, Kotaro, Satoshi Sogabe, Yusuke Kamada, et al.. (2016). Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship. Biochemical and Biophysical Research Communications. 482(2). 310–316. 26 indexed citations
8.
Tsunedomi, Ryouichi, Shoichi Hazama, Yusuke Fujita, et al.. (2014). A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes. International Journal of Oncology. 45(4). 1381–1390. 13 indexed citations
9.
Kato, Takeshi, Naoki Nagata, Makoto Fujii, et al.. (2011). Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 study.. PubMed. 31(12). 4657–64. 2 indexed citations
10.
Hayashi, Hidetoshi, Junji Tsurutani, Norikazu Masuda, et al.. (2011). Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B. Breast Cancer. 20(2). 131–136. 14 indexed citations
11.
Kobayashi, Michiya, Ken Okamoto, Tsutomu Namikawa, et al.. (2007). Laparoscopic D3 Lymph Node Dissection with Preservation of the Superior Rectal Artery for the Treatment of Proximal Sigmoid and Descending Colon Cancer. Journal of Laparoendoscopic & Advanced Surgical Techniques. 17(4). 461–466. 11 indexed citations
12.
Sakamoto, Junichi, Koji Oba, Takanori Matsui, & Michiya Kobayashi. (2006). Efficacy of Oral Anticancer Agents for Colorectal Cancer. Diseases of the Colon & Rectum. 49(1). S82–S91. 12 indexed citations
13.
Matsui, Takanori, Hiroshi Kojima, Junji Kato, et al.. (2004). A Resectable Case of Solitary Pancreatic Metastasis from Rectal Cancer. The Japanese Journal of Gastroenterological Surgery. 37(6). 692–696. 9 indexed citations
14.
Harmer, M., Mahbubur Rahman, Junichi Sakamoto, et al.. (2002). The Gallagher–Wilkinson reflex. Anaesthesia. 57(12). 1220–1221. 2 indexed citations
15.
Sakamoto, Junichi, et al.. (2000). Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer. Cancer Chemotherapy and Pharmacology. 46(S1). S27–S32. 40 indexed citations
16.
Sakamoto, Junichi, Tomoyuki Kato, Tadashi Watanabe, et al.. (1992). Detection of Locally Recurrent Colorectal Cancer with Radiolabeled Monoclonal Antibody H‐15. Japanese Journal of Cancer Research. 83(12). 1373–1381. 1 indexed citations
17.
Sakamoto, Junichi, Yasuo Ohashi, Satoshi Teramukai, et al.. (1991). Preoperative serum Immunosuppressive Acidic Protein level in the prognosis of gastric cancer.. The Japanese Journal of Gastroenterological Surgery. 24(4). 977–984. 3 indexed citations
18.
Ichihara, T, Akimasa Nakao, Junichi Sakamoto, et al.. (1989). Improvement of the rapid immunoperoxidase staining method for intraoperative pathological diagnosis of pancreatic cancer using microwave irradiation. Journal of Surgical Oncology. 42(3). 209–214. 19 indexed citations
19.
Kato, Tomoyuki, Takashi Hirai, Junichi Sakamoto, et al.. (1988). Long-term results, therapeutic problems and management in patients with large bowel cancer, with special reference to local recurrence following curative surgery for rectal cancer.. The Japanese Journal of Gastroenterological Surgery. 21(4). 1171–1174. 1 indexed citations
20.
Watanabe, Tadashi, Morimitsu Nishikimi, Seiji Akiyama, et al.. (1987). A stomach oncofetal antigen recognized by monoclonal antibody GC302. Surgery Today. 17(6). 507–516. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026